Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335894
Status:
COMPLETED
Last Update Posted:
2010-03-10
First Post:
2006-06-09
Brief Title:
Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA scin Women Undergoing COH in an ART Programme IVF
Sponsor:
IBSA Institut Biochimique SA
Organization:
IBSA Institut Biochimique SA
Study Overview
Official Title:
A Prospective Randomized Investigator-blind Controlled Clinical Study of Phase III on the Efficacy and Tolerability of hMG-IBSA IBSA vs Menopur Ferring Administered sc in Women Undergoing COH in an ART Programme IVF
Status:
COMPLETED
Status Verified Date:
2008-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Multicenter prospective randomized investigator blind controlled clinical trial Two parallel groups one receiving the test drug hMG hMG-IBSA IBSA Institut Biochimique sa and the other the reference drug hMG Menopur Ferring Pharmaceuticals Inc
Detailed Description:
The purpose of the study is to evaluate the clinical efficacy and general tolerability of two different subcutaneous hMG preparations hMG-IBSA IBSA vs Menopur Ferring Pharmaceuticals Inc when administered to patients undergoing controlled ovarian stimulation for IVF
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None